Definitive Contract 75F40118C10144

Award Date 9/25/18
Potential Completion Date 7/30/21
Potential Value $1.1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Richmond, VA 23284, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded Virginia Commonwealth University, doing business as V C U, a definitive contract valued at approximately $1.6 million to conduct an evaluation of current approaches used to establish bioequivalence of nasal sprays for local action in children. The contract is a firm fixed price award with performance taking place in Richmond, Virginia over a three-year period concluding in January 2024. No set aside designation or...
This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Virginia Commonwealth University (VCU) for sample collection services. The contract has a total ceiling value of $59,337.43 and a period of performance ending on March 31, 2022. VCU is a public research university that provides a wide range of services to the federal government, including...
This is a federal contract award made by the National Institutes of Health (NIH) to Virginia Commonwealth University (VCU), a public research university located in Richmond, Virginia. The $2,109,534 definitive contract is for biomedical research and does not have a set-aside designation. The contract has a period of performance ending on February 28, 2007. VCU has a history of providing educational services, biomedical and clinical research, and technology development support to various...
This $876,368 firm-fixed price federal contract was awarded to Virginia Commonwealth University (VCU) by the Food and Drug Administration (FDA) to conduct in vitro and in vivo assessment of buprenorphine extended release injections for generic product equivalence. The contract has a period of performance ending on September 20, 2025. This contract is not associated with a larger contract vehicle and does not have a set-aside designation. VCU has extensive experience providing biomedical research...
This federal contract award is for $126,725.04 and was issued by the Department of Justice Drug Enforcement Administration to the prime contractor, Virginia Commonwealth University (VCU), located in West Springfield, VA. The contract is for study reports and results from the scientific investigation of the in vivo analgesic effects. This is a firm fixed price purchase order with a completion date of November 30, 2019. There is no set-aside designation mentioned for this award. VCU, doing...
This is a $3,158,266.00 definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences to Virginia Commonwealth University (VCU) to conduct research on the potential for environmental and therapeutic agents to induce immunotoxicity. The contract is a cost-type award without fee and has a period of performance from July 1, 2004 to July 31, 2005. VCU, a public research university located in Richmond,...
This is a $142,857.03 firm fixed-price purchase order awarded by the Department of Justice Drug Enforcement Administration to Virginia Commonwealth University (VCU) to procure study reports and results from the scientific investigation of the in vivo analgesic effects of 20 synthetic opioid compounds. The period of performance is 6 months, ending on August 31, 2018. This contract award is not associated with a larger contract vehicle, and no set-aside designation is provided. VCU is a public...
This federal contract award, valued at $327,229, was granted to Virginia Commonwealth University (VCU) by the Shared Services Center, a civilian agency within the federal government. The contract is for a research grant to optimize the performance of carbon nanotube composites through novel multiscale modeling and machine learning methods. This award is not designated as a set-aside contract. VCU, a public research university located in Richmond, Virginia, has a history of providing educational,...
This delivery order was issued under contract SS00-15-60034 to acquire services from Virginia Commonwealth University (VCU). The contract has a firm fixed price of $192,363.00 and a completion date of July 17, 2018. VCU, a public research university located in Richmond, Virginia, has provided educational services to the U.S. Navy under the Naval Community College Partnership multiple award IDIQ vehicle, as well as conducted biomedical and clinical research services for agencies like the FDA,...
This federal contract award was issued by the U.S. government to Virginia Commonwealth University (VCU), a public research university located in Richmond, Virginia. The $131,241.50 Cooperative Agreement is for the development of "Flexible, High Performance, High Stability Sensors/Actuators for Aerospace Applications". The award does not utilize a set-aside designation. VCU is the prime contractor on this contract, which has a performance period ending on May 18, 2006. This award is...

The Department of Health and Human Services, Food and Drug Administration awarded a firm-fixed price definitive contract to Virginia Commonwealth University (VCU) to evaluate relationships between in vitro nasal spray characterization test metrics for bioequivalence and nasal deposition in silico and in vitro. The contract has a potential value of $1,136,057.48 and a completion date of July 30, 2021. VCU, a public research university located in Richmond, Virginia, has a broad range of federal prime and subcontracts across education, healthcare, biomedical research, and technology development. This contract supports the FDA's objectives related to advancing analytical testing and research on drug delivery and effectiveness.

Generated 3/21/24, 8:25 PM